Cargando…
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
BACKGROUND: The aim of this study is to find a novel molecular target based on chromosomal alteration and array-based gene expression analyses in bladder cancer (BC). We investigated a cancer testis antigen, LY6K, which is located on chromosome 8q24.3. METHODS: Five BC cell lines were subjected to h...
Autores principales: | Matsuda, R, Enokida, H, Chiyomaru, T, Kikkawa, N, Sugimoto, T, Kawakami, K, Tatarano, S, Yoshino, H, Toki, K, Uchida, Y, Kawahara, K, Nishiyama, K, Seki, N, Nakagawa, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031884/ https://www.ncbi.nlm.nih.gov/pubmed/21063397 http://dx.doi.org/10.1038/sj.bjc.6605990 |
Ejemplares similares
-
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
por: Chiyomaru, T, et al.
Publicado: (2010) -
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
por: Yoshino, H, et al.
Publicado: (2011) -
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
por: Kojima, S, et al.
Publicado: (2012) -
Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines
por: TATARANO, SHUICHI, et al.
Publicado: (2011) -
Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer
por: Matsushita, R, et al.
Publicado: (2015)